Company: HCTI
Filing Date: 2025-02-18
Form Type: 10-K/A
Source: 0001213900-25-014503
Chunk: 82

Company: Healthcare Triangle, Inc.
Filing Date: 2025-02-18
Form: 10-K/A
Chunk 82
---
 to accrued professional 
 fees.                                      |

| (viii) | The adjustment is related to reclass                                                   
 of expense to Research & Development for the intellectual property that was not proven 
 out.                                                                                   |

| (ix) | Reversal of provision for income 
 tax.                             |

| (x) | The Company issued a Secured Promissory Note on December 10, 2021, to Go To Assistance, Inc. The Company repaid the note by settling $500,000 and transfer of debt of value $1,708,841 to Seacoast Business Finance. |

F-16

Accounting Policies

Use of Estimates

The preparation of financial statements is in conformity with GAAP which requires us to make estimates, judgments and assumptions that affect the financial statements and the notes thereto. These estimates are based on information available as of the date of the financial statements. On a regular basis, management evaluates these estimates and assumptions. Items subject to such estimates and assumptions include, but are not limited to:

| ● | the standalone selling price             
 for each distinct performance obligation |

| ● | the determination of the                             
 period of benefit for amortization of deferred costs |

| ● | the fair value of assets                                     
 acquired, and liabilities assumed for business combinations. |

| ● | Share based compensation 
 including warrants       |

Going concern

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company’s operating losses raise substantial doubt about its ability to continue as a going concern and the financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Emerging Growth Company Status

We are an “emerging growth company,”
as defined in the Jumpstart Our Business Startups Act of 2012. We will remain an emerging growth company until the earlier of (i) December
21, 2026 (the last day of the fiscal year following the fifth anniversary of our IPO), (ii) the last day of the first fiscal year in which
we have total annual gross revenue of at least $ billion, (iii) the last day of the first fiscal year in which we are deemed to be
a “large accelerated filer”, as defined in the rules under the Exchange Act, and (iv) the date on which we have issued more
than $ billion in non-convertible debt during the prior three-year period. We refer to the Jumpstart Our Business Startups Act of 2012
herein as the “JO